Motor and mental development of infants exposed to antiepileptic drugs in utero

Epilepsy and Behavior

Volumn 13, Issue 1, 2008, Pages 229-236

  Thomas, Sanjeev V ^a   Ajaykumar, B ^a   Sindhu, K ^a   Nair, M K C ^b   George, Babu ^b   Sarma, P S ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

^b Child Development Centre   (India)

Author keywords

Antiepileptic drugs; Developmental toxicology; Epilepsy; Infant development; Late adverse effect; Pregnancy registry

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; FOLIC ACID; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADULT; ARTICLE; BAYLEY SCALE OF INFANT DEVELOPMENT; CHILD DEVELOPMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE DURATION; EDUCATIONAL STATUS; EPILEPSY; FEMALE; GENERALIZED EPILEPSY; HUMAN; INFANT; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MATERNAL TREATMENT; MENTAL DEVELOPMENT; MENTAL DISEASE; MONOTHERAPY; MOTOR DEVELOPMENT; MOTOR DYSFUNCTION; MULTIPLE REGRESSION; MYOCLONUS EPILEPSY; POLYPHARMACY; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; PROSPECTIVE STUDY; RATING SCALE; REGISTER; TEMPORAL LOBE EPILEPSY;

ANTICONVULSANTS; CHILD DEVELOPMENT; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; INFANT; MALE; MENTAL RETARDATION; MOVEMENT DISORDERS; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RETROSPECTIVE STUDIES;

EID: 46549087164     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2008.01.010     Document Type: Article

References (35)

1. Morrow J., Russell A., Guthrie E., et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neuropsychol Psychiatry 77 (2006) 193-198
2. Adams J., Vorhees C.V., and Middaugh L.D. Developmental neurotoxicity of anticonvulsants: human and animal evidence on phenytoin. Neurotoxicol Teratol 12 (1990) 203-214
3. Finnell R.H., and Dansky L.V. Parental epilepsy, anticonvulsant drugs and reproductive outcome: epidemiologic and experimental findings spanning three decades. 1. Animal studies. Reprod Toxicol 5 (1991) 281-299
4. Vinten J., Adab N., Kini U., Gory J., Gregg J., and Baker G.A. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 64 (2005) 949-954
5. Wide K., Winbladh B., Tomson T., and Kallen B. Body dimensions of infants exposed to antiepileptic drugs in utero: observations spanning 25 years. Epilepsia 41 (2000) 854-861
6. Wide K., Winbladh B., Tomson T., Sars-Zimmer K., and Berggren E. Psychomotor development and minor anomalies in children exposed to antiepileptic drugs in utero: a prospective population-based study. Dev Med Child Neurol. 42 (2000) 87-92
7. Wide K., Henning E., Tomson T., and Winbladh B. Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr 91 (2002) 409-414
8. Losche G., Steinhausen H.C., Koch S., and Helge H. The psychological development of children of epileptic mothers: II. The differential impact of intrauterine exposure to anticonvulsant drugs and further influential factors. Acta Paediatr 83 (1994) 961-966
9. Gaily E., Granstrom M.L., Hiilesmaa V., and Bardy A. Minor anomalies in offspring of epileptic mothers. J Pediatr 112 (1988) 520-529
10. Gaily E., Kantola-Sorsa E., and Granstrom M.L. Intelligence of children of epileptic mothers. J Pediatr 113 (1988) 677-684
11. Gaily E., and Granstrom M.L. A transient retardation of early postnatal growth in drug-exposed children of epileptic mothers. Epilepsy Res 4 (1989) 147-155
12. Gaily E., Kantola-Sorsa E., and Granstrom M.L. Specific cognitive dysfunction in children with epileptic mothers. Dev Med Child Neurol 32 (1990) 403-414
13. Gaily E.K., Granstrom M.L., Hiilesmaa V.K., and Bardy A.H. Head circumference in chidren of epileptic mothers: contributions of drug exposure and genetic background. Epilepsy Res 5 (1990) 217-222
14. Adab N., Jacoby A., Smith D., et al. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 70 (2001) 15-21
15. Granstrom M., and Gaily E. Psychomotor development in children of mothers with epilepsy. Neurology 42 Suppl. 5 (1992) 144-148
16. Adab N Tudur S.C., Vinten J., Williamson P., and Winterbottom J. Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database Syst Rev 3 (2004) CD004848
17. Thomas S.V., Indrani L., Devi G.C., et al. Pregnancy in women with epilepsy: preliminary results of Kerala Registry of Epilepsy and Pregnancy. Neurol India 49 (2001) 60-66
18. Beghi E., Annegers J.F., and Collaborative Group for the Pregnancy Registries in Epilepsy. Pregnancy Registries in Epilepsy. Epilepsia 42 (2001) 1422-1425
19. WHO Collaborative Center for Drug Statistics Methodology, World Health Organization. About the ATC/DDD system. Available at: http://www.whocc.no/atcddd/. Accessed on: 20 August 2006.
20. Phathak P. Developmental Assessment Scales for Indian Infants (DASII) Revision of 1970 Baroda norms from birth to 30 months on Bayley Scales of Infant Development (BSID). Baroda: Department of HDFS, MSUB; 1998.
21. Dean J.C.S., Hailey H., Moore S.J., Lloyd D.J., Turnpenny P.D., and Little J. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 39 (2002) 251-259
22. Leavitt A.M., Yerby M.S., Robinson N., Sells C.J., and Erickson M.D. Epilepsy in pregnancy: developmental outcome of offspring at 12 months. Neurology 42 Suppl. 5 (1992) 141-143
23. Perniola T., Buttiglione M., and Margari L. Antiepileptic drugs in pregnancy: late effects on the children's cognitive abilities. Preliminary data. Acta Neurol (Napoli) 14 (1992) 543-546
24. Mortensen J.T., Olsen J., Larsen H., Bendsen J., Obel C., and Sorensen H.T. Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics. Eur J Epidemiol 18 (2003) 769-771
25. Tamura T., Goldenberg R.L., Chapman V.R., Johnston K.E., Ramey S.L., and Nelson K.G. Folate status of mothers during pregnancy and mental and psychomotor development of their children at five years of age. Pediatrics 116 (2005) 703-708
26. Hirano T., Fujioka K., Okada M., Iwasa H., and Kaneko S. Physical and psychomotor development in the offspring born to mothers with epilepsy. Epilepsia 45 Suppl. 8 (2004) 53-57
27. Holmes L.B., Rosenberger P.B., Harvey E.A., Khoshbin S., and Ryan L. Intelligence and physical features of children of women with epilepsy. Teratology 61 (2000) 196-202
28. Reinisch J.M., Sanders S.A., Mortensen E.L., and Rubin D.B. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 274 (1995) 1518-1525
29. Thorp J.A., O'Conner M., Jones A.M.H., Hoffman E.L., and Belden B. Does perinatal phenobarbital exposure affect development outcome at age 2?. Am J Perinatol 16 (1999) 51-60
30. Adams J., Harvey E.A., and Holmes L.B. Cognitive deficits following gestational monotherapy with phenobarbital and carbamazepine. Neurotoxicol Teratol 22 (2000) 466
31. Vanoverloop D., Schnell R.R., Harvey E.A., and Holmes L.B. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol 14 (1992) 329-335
32. Scolnik D., Nulman I., Rovet J., et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 271 (1994) 767-770
33. Gaily E., Kantola-Sorsa E., Hiilesmaa V., and Isoaho M. Normal intelligence in children with prenatal exposure to carbamazepine Neurology 62 (2004) 28-32
34. Eriksson K., Viinikainen K., Monkkonen A., et al. Children exposed to valproate in utero: population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 65 (2005) 189-200
35. Rasalam A.D., Hailey H., Williams J.H., et al. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 47 (2005) 551-555